Tag: Dilnot proposals

Latest articles

Review of national cancer screening programmes in England published

Review of national cancer screening programmes in England published

The NHS has the opportunity to upgrade cancer screening to save thousands more lives each year, according to a major report. Leading expert Professor Sir...
Bristol-Myers Squibb-Pfizer Alliance and Fitbit collaborate on atrial fibrillation diagnosis

Bristol-Myers Squibb-Pfizer Alliance and Fitbit collaborate on atrial fibrillation diagnosis

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New York that they are working together to help drive...
Contracts awarded to deliver urgent medicines after Brexit

Contracts awarded to deliver urgent medicines after Brexit

The Government has awarded contracts to deliver urgent medicines after Brexit. Three companies have been awarded the contracts for express freight service to deliver...

Popular articles

Licence secured for first UK medicinal cannabis distribution centre

Licence secured for first UK medicinal cannabis distribution centre

Spectrum Therapeutics has secured licences for the first UK medicinal cannabis distribution centre. Spectrum Therapeutics UK received licences from the UK Medicines and Healthcare products...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Research identifies cause of IBS pain as 'gut itch'

Research identifies cause of IBS pain as ‘gut itch’

New research has identified the cause of IBS pain as 'gut itch'. 11 percent of the world’s population experience Irritable Bowel Syndrome (IBS), but the...
Review of national cancer screening programmes in England published

Review of national cancer screening programmes in England published

The NHS has the opportunity to upgrade cancer screening to save thousands more lives each year, according to a major report. Leading expert Professor Sir...
pharmafield logo - pharma news

The Twilight Zone

Classified drugs, which are potentially dangerous and liable to abuse, have legitimate uses but also turn up on the black market. What does this mean for industry – and how has the internet affected this problem?

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription